Optimal initial diet in mild acute pancreatitis: A comprehensive meta-analysis of randomized control trials

Pancreatology. 2022 Nov;22(7):858-863. doi: 10.1016/j.pan.2022.07.016. Epub 2022 Aug 11.

Abstract

Objective: We performed a comprehensive systematic review and meta-analysis comparing initiation of full solid diet (FSD) versus stepwise diet to better define the management of patients with mild acute pancreatitis (AP).

Methods: Electronic databases were searched through August 2, 2021 for trials comparing initial FSD versus stepwise advancement in patients with mild AP on length of hospital stay (LOHS). We stratified by whether diet was initiated early (within 24 h or immediately upon presence of bowel sounds).

Results: We identified seven RCTs that compared LOHS in AP patients who received initial oral intake with solid diet versus stepwise diet. Across the studies a total of 305 patients were randomized to immediate FSD and 308 patients to sequential advancement. Patients who were initiated on a FSD had a significant reduction in total LOHS (Standardized Mean Difference (SMD) -0.52 [95% CI -0.69, -0.36]). There was no difference in post refeeding abdominal pain, tolerance of diet, or necessity to cease diet between the two groups. Sub-analysis of three studies that initiated FSD early reduced total LOHS (OR -0.95 [95% CI -1.26, -0.65]) compared to those who received graded diet advancement as well as higher likelihood of tolerating the assigned diet (OR 6.8 [95% CI 1.2, 39.2]).

Conclusions: Our meta-analysis shows that initiation of FSD reduces total LOHS in patients with mild AP and does not increase post refeeding abdominal pain. Though additional high-quality studies are needed, these findings support initial solid diet for AP and consideration of feeding within the first 24 h.

Keywords: Abdominal pain; Diet therapy; Pancreatitis.

Publication types

  • Meta-Analysis

MeSH terms

  • Abdominal Pain
  • Acute Disease
  • Diet
  • Humans
  • Length of Stay
  • Pancreatitis* / therapy
  • Randomized Controlled Trials as Topic